Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
NCT ID: NCT05596344
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2023-05-20
2032-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients
NCT03290001
Impact of Psychological Stress on Treatment Response and Prognosis in Lung Cancer Patients
NCT06964503
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214
The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
NCT06220630
Olfactory Change After Chemo-radiotherapy for Nasopharyngeal Carcinoma
NCT05146050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hospital Anxiety and Depression Scale
The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Pathological diagnosis of malignant tumor in our hospital.
3. Received at least one hospitalization at this hospital.
4. The expected survival time is greater than 1 year.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henan Cancer Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wang Jiaqiang
associate chief physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZZUSC-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.